Australia markets closed

Biohaven Ltd. (BHVN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
16.93-0.26 (-1.51%)
At close: 04:00PM EDT
16.90 -0.03 (-0.18%)
After hours: 07:40PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close17.19
Bid16.71 x 800
Ask16.95 x 1000
Day's range16.69 - 17.18
52-week range5.54 - 26.64
Avg. volume863,872
Market cap1.157B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Simply Wall St.

    Independent Director of Biohaven Picks Up 1.8% More Stock

    Those following along with Biohaven Ltd. ( NYSE:BHVN ) will no doubt be intrigued by the recent purchase of shares by...

  • Motley Fool

    Why Biohaven Stock Is Crashing Today

    What happened Shares of Biohaven Ltd. (NYSE: BHVN) were crashing 27.5% lower at 11:50 a.m. ET on Thursday. This big sell-off came after the company provided updates on several programs. The most important news for investors is related to Biohaven's New Drug Application (NDA) filing for troriluzole in treating spinocerebellar ataxia type 3 (SCA3), an ultrarare neurodegenerative disorder.

  • Motley Fool

    2 Growth Stocks With Major Incoming Catalysts

    Then you want to check out this pair of drugmakers with huge catalysts on the way. Before blindly risking any of your own hard-earned money, let's look at the catalysts that could make these two top performers. BridgeBio (NASDAQ: BBIO) is a commercial-stage drugmaker with one drug for sale.